Clinical Trials in France / NCT05632419
Recruiting
Observational
Prognosis of Patients Who Presented With a State of Extreme Agitation.
NCT05632419 · tracked via the Priya Life Science France tracker
Condition(s) studied
Emergence Delirium
Study summary
The main objective is to assess the 6-month prognosis of patients who presented with extreme agitation in the emergency room.
The primary endpoint is the 6-month mortality of agitated patients.
Eligibility
Inclusion Criteria:
* Agitated patient with the presence of three major criteria, namely,
* restlessness
* insensitivity to pain
* tachypnea (fr\>20)
and the presence of a minor criterion among
* sweating
* skin hyperthermia
* non-compliance with law enforcement
* tirelessness
* unusual strength
* inappropriate clothing, nudity
Exclusion Criteria:
* patient age \< 18 years
* head trauma
* pregnancy
* detained
* other obvious causes of pain leading to restlessness (renal colic, migraines, etc.)
Primary outcome measure(s)
- Number of deceased patients — 6 months
The 6-month prognosis of patients who presented with extreme agitation in the emergency room.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Avicenne Hospital - Aphp | Bobigny | Île-de-France Region | Recruiting |
More Assistance Publique - Hôpitaux de Paris trials in France
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT05632419 on ClinicalTrials.gov ↗ ← All trials in France